Larry Biegelsen
Stock Analyst at Wells Fargo
(4.03)
# 1,762
Out of 4,685 analysts
1329
Total ratings
53.5%
Success rate
4.4%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies | Rated: Buy | $85 | $72.48 | +17.27% | 29 | Aug 25, 2026 | |
| MDT Medtronic | Maintained: Buy | $102 | $89.97 | +13.37% | 89 | Aug 24, 2026 | |
| ABT Abbott Laboratories | Rated: Buy | $112 | $111.59 | +0.37% | 113 | Aug 20, 2026 | |
| HTFL HeartFlow | Rated: Buy | $37 → $39 | $48.10 | -18.92% | 4 | Aug 14, 2026 | |
| AVR Anteris Technologies Global | Maintained: Buy | $16 | $8.97 | +78.37% | 5 | Aug 13, 2026 | |
| NPCE NeuroPace | Rated: Buy | $19 | $14.13 | +34.47% | 13 | Aug 12, 2026 | |
| ENOV Enovis | Maintained: Buy | $40 → $39 | $24.83 | +57.07% | 4 | Aug 7, 2026 | |
| GMED Globus Medical | Maintained: Buy | $103 → $99 | $82.54 | +19.94% | 13 | Aug 7, 2026 | |
| ZBH Zimmer Biomet Holdings | Rated: Hold | $90 → $103 | $99.48 | +3.54% | 43 | Aug 6, 2026 | |
| RXST RxSight | Maintained: Hold | $9 | $6.61 | +36.16% | 26 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $14 | $9.57 | +46.29% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $255 → $144 | $143.41 | +0.41% | 40 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $56 | $60.82 | -7.93% | 39 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $272 → $282 | $265.77 | +6.11% | 99 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $374 | $321.00 | +16.51% | 48 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 → $90 | $89.29 | +0.80% | 63 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $74 → $83 | $89.54 | -7.30% | 43 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $39 → $46 | $50.32 | -8.59% | 3 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $18 | $16.85 | +6.82% | 14 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $138 → $178 | $181.91 | -2.15% | 56 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $50 | $46.67 | +7.14% | 51 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $487 | $367.07 | +32.67% | 61 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 | $25.81 | +8.49% | 6 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $418 | $322.12 | +29.77% | 39 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $26 | $19.51 | +33.26% | 3 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $82 → $66 | $70.96 | -6.99% | 44 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $21 → $27 | $21.40 | +26.17% | 31 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $70 | $90.93 | -23.02% | 3 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $116 → $138 | $137.71 | +0.21% | 20 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $14 → $17 | $17.99 | -5.50% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $48 | $51.73 | -7.21% | 2 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | CHF 70.86 → CHF 78.11 | CHF 58.46 | +33.61% | 33 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $80 → $84 | $125.30 | -32.96% | 3 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $18 | $17.13 | +5.08% | 57 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 → $100 | $89.95 | +11.17% | 65 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $184 → $157 | $188.13 | -16.55% | 40 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $280 → $270 | $235.76 | +14.52% | 2 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $19 | $25.93 | -26.73% | 36 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $2.42 | +23.97% | 22 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8454 | - | 15 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $20 | $100.47 | n/a | 3 | Aug 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $1.4 | $10.92 | n/a | 3 | Sep 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $154.65 | n/a | 1 | Jan 4, 2010 |
GE HealthCare Technologies
Aug 25, 2026
Rated: Buy
Price Target: $85
Current: $72.48
Upside: +17.27%
Medtronic
Aug 24, 2026
Maintained: Buy
Price Target: $102
Current: $89.97
Upside: +13.37%
Abbott Laboratories
Aug 20, 2026
Rated: Buy
Price Target: $112
Current: $111.59
Upside: +0.37%
HeartFlow
Aug 14, 2026
Rated: Buy
Price Target: $37 → $39
Current: $48.10
Upside: -18.92%
Anteris Technologies Global
Aug 13, 2026
Maintained: Buy
Price Target: $16
Current: $8.97
Upside: +78.37%
NeuroPace
Aug 12, 2026
Rated: Buy
Price Target: $19
Current: $14.13
Upside: +34.47%
Enovis
Aug 7, 2026
Maintained: Buy
Price Target: $40 → $39
Current: $24.83
Upside: +57.07%
Globus Medical
Aug 7, 2026
Maintained: Buy
Price Target: $103 → $99
Current: $82.54
Upside: +19.94%
Zimmer Biomet Holdings
Aug 6, 2026
Rated: Hold
Price Target: $90 → $103
Current: $99.48
Upside: +3.54%
RxSight
Aug 6, 2026
Maintained: Hold
Price Target: $9
Current: $6.61
Upside: +36.16%
Aug 5, 2026
Maintained: Buy
Price Target: $28 → $14
Current: $9.57
Upside: +46.29%
Aug 5, 2026
Downgraded: Hold
Price Target: $255 → $144
Current: $143.41
Upside: +0.41%
Aug 4, 2026
Maintained: Hold
Price Target: $56
Current: $60.82
Upside: -7.93%
Aug 3, 2026
Maintained: Buy
Price Target: $272 → $282
Current: $265.77
Upside: +6.11%
Aug 3, 2026
Maintained: Hold
Price Target: $374
Current: $321.00
Upside: +16.51%
Jul 31, 2026
Maintained: Buy
Price Target: $85 → $90
Current: $89.29
Upside: +0.80%
Jul 31, 2026
Rated: Hold
Price Target: $74 → $83
Current: $89.54
Upside: -7.30%
Jul 30, 2026
Maintained: Hold
Price Target: $39 → $46
Current: $50.32
Upside: -8.59%
Jul 30, 2026
Maintained: Hold
Price Target: $15 → $18
Current: $16.85
Upside: +6.82%
Jul 30, 2026
Rated: Buy
Price Target: $138 → $178
Current: $181.91
Upside: -2.15%
Jul 29, 2026
Maintained: Hold
Price Target: $55 → $50
Current: $46.67
Upside: +7.14%
Jul 23, 2026
Maintained: Buy
Price Target: $487
Current: $367.07
Upside: +32.67%
Jul 15, 2026
Rated: Buy
Price Target: $28
Current: $25.81
Upside: +8.49%
Jul 8, 2026
Maintained: Buy
Price Target: $418
Current: $322.12
Upside: +29.77%
Jun 8, 2026
Maintained: Buy
Price Target: $22 → $26
Current: $19.51
Upside: +33.26%
Jun 5, 2026
Maintained: Hold
Price Target: $82 → $66
Current: $70.96
Upside: -6.99%
Jun 1, 2026
Upgraded: Buy
Price Target: $21 → $27
Current: $21.40
Upside: +26.17%
May 22, 2026
Maintained: Hold
Price Target: $70
Current: $90.93
Upside: -23.02%
May 8, 2026
Maintained: Hold
Price Target: $116 → $138
Current: $137.71
Upside: +0.21%
May 4, 2026
Rated: Hold
Price Target: $14 → $17
Current: $17.99
Upside: -5.50%
Apr 29, 2026
Maintained: Buy
Price Target: $40 → $48
Current: $51.73
Upside: -7.21%
Feb 26, 2026
Upgraded: Buy
Price Target: CHF 70.86 → CHF 78.11
Current: CHF 58.46
Upside: +33.61%
Feb 20, 2026
Maintained: Hold
Price Target: $80 → $84
Current: $125.30
Upside: -32.96%
Feb 19, 2026
Maintained: Hold
Price Target: $17 → $18
Current: $17.13
Upside: +5.08%
Feb 11, 2026
Reiterated: Buy
Price Target: $96 → $100
Current: $89.95
Upside: +11.17%
Feb 10, 2026
Maintained: Hold
Price Target: $184 → $157
Current: $188.13
Upside: -16.55%
Jan 30, 2026
Maintained: Hold
Price Target: $280 → $270
Current: $235.76
Upside: +14.52%
Dec 12, 2025
Maintained: Hold
Price Target: $24 → $19
Current: $25.93
Upside: -26.73%
Nov 13, 2025
Maintained: Hold
Price Target: $3
Current: $2.42
Upside: +23.97%
Oct 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.8454
Upside: -
Aug 2, 2018
Reiterated: Buy
Price Target: $26 → $20
Current: $100.47
Upside: n/a
Sep 26, 2013
Downgraded: Hold
Price Target: $15 → $1.4
Current: $10.92
Upside: n/a
Jan 4, 2010
Upgraded: Buy
Price Target: n/a
Current: $154.65
Upside: n/a